---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-229749"
form_type: "8-K"
ticker: "HIMS"
cik: "0001773751"
company_name: "Hims & Hers Health, Inc."
filed_at: "2026-05-19T12:17:31+00:00"
generated_at: "2026-05-19T12:21:19.655394+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Hims & Hers prices $350M 0.00% convertible notes due 2032; funds Eucalyptus acquisition & AI

## Summary
- Offering upsized from $300M to $350M; initial purchasers can buy additional $52.5M.
- Notes mature June 1, 2032; zero coupon; initial conversion price ~$29.53/share (32.5% premium over $22.29 close).
- Net proceeds ~$338.5M; $32M for capped call transactions; remainder for international expansion, including Eucalyptus acquisition, AI, and infrastructure.
- Capped call transactions reduce dilution, cap price initially ~$50.15/share.
- Settlement expected May 21, 2026; Eucalyptus acquisition expected mid-2026.

## SEC filing metadata
- accession: 0001193125-26-229749
- form_type: 8-K
- ticker: HIMS
- cik: 0001773751
- company_name: Hims & Hers Health, Inc.
- filed_at: 2026-05-19T12:17:31+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1773751/000119312526229749/0001193125-26-229749-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1773751/000119312526229749/d227898d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-229749
- JSON: https://secwatch.observer/filing/0001193125-26-229749.json
- Plain text: https://secwatch.observer/filing/0001193125-26-229749.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.